Politicians
Bills
House Bill 5657
117th Congress(2021-2022)
Medical Marijuana Research Act
Active
Active
Passed House on Apr 4, 2022
Overview
Text
Introduced
Oct 21, 2021
Latest Action
Apr 5, 2022
Origin Chamber
House
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
5657
Congress
117
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
Sponsorship by Party
Democrat
Earl Blumenauer
Oregon
Democrat
Chris Pappas
New Hampshire
Democrat
Eleanor Holmes Norton
District of Columbia
Democrat
Ed Case
Hawaii
Republican
Andy Harris
Maryland
Democrat
Debbie Dingell
Michigan
Democrat
Ed Perlmutter
Colorado
Republican
Dave Joyce
Ohio
Democrat
Barbara Lee
California
Republican
Nancy Mace
South Carolina
Democrat
Steve Cohen
Tennessee
Republican
Morgan Griffith
Virginia
House Votes (2)
Senate Votes (0)
Passed
April 4, 2022
Type
Final Passage Under Suspension Of The Rules Results
House Roll Call Votes
Summary

Medical Marijuana Research Act

This bill establishes a new, separate registration process to facilitate medical marijuana research.

Specifically, it directs the Drug Enforcement Administration to register (1) practitioners to conduct medical marijuana research, and (2) manufacturers and distributors to supply marijuana for such research.

Additionally, the Department of Health and Human Services must continue to produce marijuana through the National Institute on Drug Abuse Drug Supply Program and implement a specialized process for supplying marijuana products available through state-authorized marijuana programs to researchers until manufacturers and distributors can provide a sufficient supply of marijuana for medical research.

Text (2)
Engrossed in House
April 4, 2022
Introduced in House
October 21, 2021
Actions (13)
04/05/2022
Received in the Senate.
04/04/2022
Motion to reconsider laid on the table Agreed to without objection.
04/04/2022
On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 343 - 75 (Roll no. 108). (text: CR H4136-4138)
04/04/2022
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 343 - 75 (Roll no. 108).(text: CR H4136-4138)
04/04/2022
Considered as unfinished business. (consideration: CR H4144-4145)
04/04/2022
At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.
04/04/2022
DEBATE - The House proceeded with forty minutes of debate on H.R. 5657.
04/04/2022
Considered under suspension of the rules. (consideration: CR H4136-4140)
04/04/2022
Mr. Pallone moved to suspend the rules and pass the bill, as amended.
10/22/2021
Referred to the Subcommittee on Health.
10/21/2021
Referred to the Committee on Energy and Commerce, and in addition to the Committees on the Judiciary, and the Budget, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
10/21/2021
Sponsor introductory remarks on measure. (CR E1126)
10/21/2021
Introduced in House
Public Record
Record Created
Oct 22, 2021 7:12:15 AM
Record Updated
Apr 18, 2022 4:15:26 PM
Copyright © 2022 Civic Bits LLC
Privacy Policy
Terms of Service
What's New
About